Qrem is a start-up founded in Barcelona in 2016 engaged to regenerative medicine that develops, manufactures and markets medical devices.
Its mission is to promote the standardization and scalability of autologous regenerative therapies, making available to physicians Lab-in-a-Box bioengineering systems to carry out these therapies in their own offices in an easy and closed way so that due to their cost-effectiveness, they reach the largest number of patients possible.
Qrem Cytokine, the company's first product to be marketed since 2018, automates and standardizes the production of an Autologous Cytokine-Rich Serum (ACRS) from a patient's blood.
Healthcare professionals can treat various indications requiring tissue repair or regeneration by locally injecting the ACRS into the treatment area.
Qrem currently markets its products in 11 European countries and is working to position ACRS as a premium treatment for tendinopathies and wound care, aiming for exponential international growth. For this reason, it is seeking a €2 million Series A funding round.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
About our Pharma Services
Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing through our Patheon™ brand. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. https://www.patheon.com/us/en/home.html
Thermo Fisher Scientific’s partnership goal is to collaborate closely with customers by providing integrated solutions—from research tools to Patheon CDMO services—that accelerate innovation and enable the efficient development and delivery of life-changing therapies.
